Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Transport of the Ruthenium Complex [Ru(GA)(dppe)(2)]PF6 into Triple-Negative Breast Cancer Cells Is Facilitated by Transferrin Receptors

Full text
Author(s):
Naves, Marina A. [1] ; Graminha, Angelica E. [1] ; Vegas, Legna C. [2] ; Luna-Dulcey, Liany [1] ; Honorato, Joao [2] ; Menezes, Antonio C. S. [3] ; Batista, Alzir A. [2] ; Cominetti, Marcia R. [1]
Total Authors: 8
Affiliation:
[1] Univ Fed Sao Carlos, Lab Biol Aging LABEN, Dept Gerontol, BR-13565905 Sao Carlos, SP - Brazil
[2] Univ Fed Sao Carlos, Lab Struct & React Inorgan Cpds LERCI, Dept Chem, BR-13565905 Sao Carlos, SP - Brazil
[3] State Univ Goias, Campus Exact Sci & Technol CCET, BR-75132903 Anapolis, GO - Brazil
Total Affiliations: 3
Document type: Journal article
Source: MOLECULAR PHARMACEUTICS; v. 16, n. 3, p. 1167-1183, MAR 2019.
Web of Science Citations: 2
Abstract

The triple-negative breast cancer subtype (TNBC) is highly aggressive and metastatic and corresponds to 15-20% of diagnosed cases. TNBC treatment is hampered, because these cells usually do not respond to hormonal therapy, and they develop resistance to chemotherapeutic drugs. On the other hand, the severe side effects of cisplatin represent an obstacle for its clinical use. Ruthenium (Ru)-based complexes have emerged as promising antitumor and antimetastatic substitutes for cisplatin. In this study, we demonstrated the effects of a Ru/biphosphine complex, containing gallic acid (GA) as a ligand, {[}Ru(GA)(dppe)(2)]PF6, hereafter called Ru(GA), on a TNBC cell line, and compared them to the effects in a nontumor breast cell line. Ru(GA) complex presented selective cytotoxicity against TNBC over nontumor cells, inhibited its migration and invasion, and induced apoptosis. These effects were associated with the increased amount of transferrin receptors (TfR) on tumor cells, compared to nontumor ones. Silencing of TfR decreased Ru(GA) effects on TNBC cells, demonstrating that these receptors were at least partially responsible for Ru(GA) delivery into tumor cells. The Ru(GA) compound must be further studied in different in vivo assays in order to investigate its antitumor properties and its toxicity in complex biological systems. (AU)

FAPESP's process: 16/16312-0 - CYTOTOXICITY AND MECHANISM OF ACTION OF RUTHENIUM COMPLEXES CONTAINING NATURAL PRODUCTS OR DERIVATIVES
Grantee:Alzir Azevedo Batista
Support Opportunities: Regular Research Grants
FAPESP's process: 15/24940-8 - EFFECTIVENESS OF STRUCTURAL CHANGES IN [10]-GINGEROL MOLECULE IN COMBINATION WITH THE CHEMOTHERAPEUTIC DOXORUBICIN FOR THE TREATMENT OF BREAST CANCER: IN VITRO AND IN VIVO STUDIES. ABSTRACT
Grantee:Márcia Regina Cominetti
Support Opportunities: Regular Research Grants
FAPESP's process: 13/00798-2 - The extracellular matrix in aging, exercise and in the tumor microenvironment
Grantee:Heloisa Sobreiro Selistre de Araújo
Support Opportunities: Research Projects - Thematic Grants